<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:pugpig="http://schema.pugpig.com/rss/" xmlns:content="http://purl.org/rss/1.0/modules/content/" 
	xmlns:media="http://search.yahoo.com/mrss/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
	<channel>
		<title>Scientific American</title> 
		<link>http://www.scientificamerican.com</link>
		<description>Science news and technology updates from Scientific American</description> 
		<image><url>https://static.scientificamerican.com/sciam/assets/Image/newsletter/salogo.png</url><title>Scientific American</title><link>http://www.scientificamerican.com</link></image> 
		<pubDate>Thu, 07 Mar 2024 20:22:18 GMT</pubDate> 
		<language>en-us</language>
		<copyright>Scientific American, a Division of Springer Nature America, Inc.</copyright>
		<itunes:author>Scientific American</itunes:author>
		<itunes:owner><itunes:email>multimedia@sciam.com</itunes:email></itunes:owner>
						<item>
							<title>A New Type of Cancer Drug Shrinks Hard-to-Treat Tumors</title>
							<link>https://www.scientificamerican.com/article/a-new-type-of-cancer-drug-shrinks-hard-to-treat-tumors/</link>
							<guid isPermaLink="false">42854041-4B79-4BE8-BAD48B67BBAD676B</guid>
							<pubDate>Wed, 21 Feb 2024 17:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;New drugs called antibody-drug conjugates help patients with cancers that used to be beyond treatment&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/0B3D3F35-91F9-45F4-9D6715267502E59D_source.jpg" fileSize="102532" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Keith Negley]]></media:credit>
			</media:content><dc:creator>Jyoti Madhusoodanan</dc:creator><category>Features</category><category>Health</category><category>Pharmaceuticals</category></item>
						<item>
							<title>AI Program Finds Thousands of Possible Psychedelics. Will They Lead to New Drugs?</title>
							<link>https://www.scientificamerican.com/article/ai-program-finds-thousands-of-possible-psychedelics-will-they-lead-to-new-drugs/</link>
							<guid isPermaLink="false">4AC4DB66-B223-4743-8C285CECC333D374</guid>
							<pubDate>Tue, 23 Jan 2024 14:30:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Researchers have doubted how useful AI protein-structure tool AlphaFold will be in discovering medicines&amp;mdash;now they are learning how to deploy it effectively&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Researchers have doubted how useful AI protein-structure tool AlphaFold will be in discovering medicines&amp;mdash;now they are learning how to deploy it effectively&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/87D64A71-5DE8-490C-B5B3D78B779B58F8_source.jpg" fileSize="1571158" type="image/jpeg" expression="full" width="790" height="496">
				<media:description type="html"><![CDATA[Computer artwork of an LSD (<em>Lysergic acid diethylamide</em>) molecule.]]></media:description>
				<media:credit><![CDATA[Science Lab/Alamy Stock Photo]]></media:credit>
			</media:content><dc:creator>Ewen Callaway, Nature magazine</dc:creator><category>Health</category><category>Pharmaceuticals</category><category>Technology</category><category>Artificial Intelligence</category></item>
						<item>
							<title>Lower Drug Costs Are Just a Federal License Away. But They Require Biden Administration Leadership</title>
							<link>https://www.scientificamerican.com/article/lower-drug-costs-are-just-a-federal-license-away-but-they-require-biden-administration-leadership/</link>
							<guid isPermaLink="false">E82A4CE4-8C07-4E4C-81999A0D2280E6D6</guid>
							<pubDate>Tue, 23 Jan 2024 12:30:00 GMT</pubDate>
							<atom:updated>Wed, 31 Jan 2024 15:27:18 GMT</atom:updated>
							<standfirst>&lt;p&gt;It&amp;rsquo;s a longstanding government failure to never use federal &amp;ldquo;march-in&amp;rdquo; licensing rights to lower drug prices. It&amp;rsquo;s also a mistake to limit them to only a few cases&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;It&amp;rsquo;s a longstanding government failure to never use federal &amp;ldquo;march-in&amp;rdquo; licensing rights to lower drug prices. It&amp;rsquo;s also a mistake to limit them to only a few cases&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/FFC2004D-DAAD-4D8B-8F4DC03DE7F4BD27_source.jpg" fileSize="3232659" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Opticopia/Getty Images]]></media:credit>
			</media:content><dc:creator>James Love</dc:creator><category>Health</category><category>Medicine</category><category>Pharmaceuticals</category></item>
						<item>
							<title>The New Year Resolution We Need Is to Avoid Miracle Cures</title>
							<link>https://www.scientificamerican.com/article/the-new-year-resolution-we-need-is-to-avoid-miracle-cures/</link>
							<guid isPermaLink="false">81678C73-DEEA-47FA-B850D1A11AF90F40</guid>
							<pubDate>Mon, 22 Jan 2024 12:30:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Bad diets, stress, impaired sleep and aging can&amp;rsquo;t be reversed by juicing, healing crystals or influencer-endorsed pills. Don&amp;rsquo;t buy them&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Bad diets, stress, impaired sleep and aging can&amp;rsquo;t be reversed by juicing, healing crystals or influencer-endorsed pills. Don&amp;rsquo;t buy them&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/E2ECA6E8-99D2-4FC7-9E3A0F88A7B21DBF_source.jpg" fileSize="1243231" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[mixetto/Getty Images]]></media:credit>
			</media:content><dc:creator>David Robert Grimes</dc:creator><category>Health</category><category>Diet</category><category>Medicine</category><category>Pharmaceuticals</category><category>Public Health</category></item>
						<item>
							<title>Asthma Drug Still Being Prescribed to Kids Despite Potential Mental Health Risks</title>
							<link>https://www.scientificamerican.com/article/asthma-drug-still-being-prescribed-to-kids-despite-potential-mental-health-risks/</link>
							<guid isPermaLink="false">22BBFFF5-BE9F-465F-A8088C04A74C3900</guid>
							<pubDate>Fri, 19 Jan 2024 17:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;The allergy and asthma drug montelukast, also known as Singulair, can cause psychiatric side effects&amp;mdash;and researchers aren&amp;rsquo;t sure why&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;The allergy and asthma drug montelukast, also known as Singulair, can cause psychiatric side effects&amp;mdash;and researchers aren&amp;rsquo;t sure why&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/C4C34479-564F-4A34-A57F4A2BCC39731C_source.jpg" fileSize="3166423" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Alihan Usullu/Getty Images]]></media:credit>
			</media:content><dc:creator>Joanna Thompson</dc:creator><category>Health</category><category>Pharmaceuticals</category><category>Mind &amp; Brain</category><category>Mental Health</category></item>
						<item>
							<title>When Choosing What Diseases to Develop Drugs For, It All Comes Down to Funding</title>
							<link>https://www.scientificamerican.com/article/when-choosing-what-diseases-to-develop-drugs-for-it-all-comes-down-to-funding/</link>
							<guid isPermaLink="false">CB06A32C-F183-4F78-B40723B411D6DF4B</guid>
							<pubDate>Fri, 12 Jan 2024 13:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Prescription drugs and vaccines have revolutionized healthcare, but how do researchers and industry decide what diseases to pursue?&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Prescription drugs and vaccines have revolutionized healthcare, but how do researchers and industry decide what diseases to pursue?&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/BC2412FA-1388-43B7-877759A80E201C16_source.jpg" fileSize="6163608" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[solarseven/Getty Images]]></media:credit>
			</media:content><dc:creator>C. Michael White, The Conversation US</dc:creator><category>Health</category><category>Pharmaceuticals</category></item>
						<item>
							<title>5 Ways Ozempic and Other New Weight-Loss Drugs Have Changed Health</title>
							<link>https://www.scientificamerican.com/article/5-ways-ozempic-and-other-new-weight-loss-drugs-have-changed-health/</link>
							<guid isPermaLink="false">A7A87D23-CA32-45B5-AF8D925B504CF3CA</guid>
							<pubDate>Fri, 29 Dec 2023 17:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/FB689D8D-8D24-43DA-A6F4473B4B1BD271_source.jpg" fileSize="3940615" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Mario Tama/Getty Images]]></media:credit>
			</media:content><dc:creator>Lauren J. Young</dc:creator><category>Health</category><category>Pharmaceuticals</category></item>
						<item>
							<title>How Two Pharmacists Figured Out That Decongestants Don&apos;t Work</title>
							<link>https://www.scientificamerican.com/article/how-two-pharmacists-figured-out-that-decongestants-dont-work/</link>
							<guid isPermaLink="false">4F984684-678C-4676-AD467DE398642B5F</guid>
							<pubDate>Thu, 21 Dec 2023 12:30:00 GMT</pubDate>
							<atom:updated>Thu, 15 Feb 2024 20:37:35 GMT</atom:updated>
							<standfirst>&lt;p&gt;A loophole in FDA processes means older drugs such as those in oral decongestants weren&amp;rsquo;t properly tested. Here&amp;rsquo;s how we learned the most popular one doesn&amp;rsquo;t work&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;A loophole in FDA processes means older drugs such as those in oral decongestants weren&amp;rsquo;t properly tested. Here&amp;rsquo;s how we learned the most popular one doesn&amp;rsquo;t work&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/52C7F159-D5BD-4273-AB8C0C05C6F9E83B_source.jpg" fileSize="198438" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Jelle Wagenaar]]></media:credit>
			</media:content><dc:creator>Randy Hatton</dc:creator><category>Features</category><category>Health</category><category>Pharmaceuticals</category></item>
						<item>
							<title>New Class of Antibiotics Discovered Using AI</title>
							<link>https://www.scientificamerican.com/article/new-class-of-antibiotics-discovered-using-ai/</link>
							<guid isPermaLink="false">A20D28A8-5C52-4A27-90195C58D73A64AE</guid>
							<pubDate>Wed, 20 Dec 2023 16:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;A deep-learning algorithm helped identify new compounds that are effective against antibiotic-resistant infections in mice, opening the door to AI-guided drug discovery&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;A deep-learning algorithm helped identify new compounds that are effective against antibiotic-resistant infections in mice, opening the door to AI-guided drug discovery&lt;/p&gt;</description>
			<media:content url="https://static.scientificamerican.com/sciam/cache/file/B0612C40-8B54-49BD-8B0B9703042404BD_source.jpg" fileSize="1329621" type="image/jpeg" expression="full" width="790" height="496">
				
				<media:credit><![CDATA[Eoneren/Getty Images]]></media:credit>
			</media:content><dc:creator>Tanya Lewis</dc:creator><category>Health</category><category>Pharmaceuticals</category><category>Technology</category><category>Artificial Intelligence</category></item>
	</channel>
</rss>
		